skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Pharmacological characterization of. cap alpha. /sub 2/-adrenoceptor heterogeneity

Thesis/Dissertation ·
OSTI ID:7027159

Utilizing the techniques of radioligand binding assay and quantitative autoradiography, evidence is provided for the existence of a heterogeneous population of ..cap alpha../sub 2/-adrenoceptors, which is present in central as well as peripheral tissues, and across two species. In rat brain, the autoradiographic distributions of binding sites labeled by two reportedly selective ..cap alpha../sub 2/-adrenoceptor antagonists, (/sup 3/H) rauwolscine and (/sup 3/H) idazoxan, differed markedly throughout the neuraxis. Whereas (/sup 3/H)idazoxan labeling appeared over brain regions receiving noradrenergic innervations, (/sup 3/H)rauwolscine binding sites were localized most densely in several areas corresponding to dopaminergic terminal fields. In areas labeled by (/sup 3/H)rauwolscine, the maximal binding densities for (/sup 3/H)idazoxan labeling were consistently greater than those for (/sup 3/H)rauwolscine sites. The autoradiographic distributions of (/sup 3/H)idazoxan and (/sup 3/H)-rauwolscine binding sites throughout monkey brain were very similar to those observed in rat brain, suggesting that the R/sub I/ and R/sub S/ sites characterized in the rodent central nervous system may also exist in primate brain.

Research Organization:
California Univ., Irvine (USA)
OSTI ID:
7027159
Resource Relation:
Other Information: Thesis (Ph. D.)
Country of Publication:
United States
Language:
English